FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2045477218> ?p ?o ?g. }

• W2045477218 endingPage "e810" @default.
• W2045477218 startingPage "e810" @default.
• W2045477218 abstract "Epidermal growth factor receptor (EGFR), which promotes cell survival and division, is found at abnormally high levels on the surface of many cancer cell types, including many cases of non-small cell lung cancer. Erlotinib (Tarceva), an oral small-molecule tyrosine kinase inhibitor, is a so-called targeted drug that inhibits the tyrosine kinase domain of EGFR, and thus targets cancer cells with some specificity while doing less damage to normal cells. However, erlotinib resistance can occur, reducing the efficacy of this treatment. To develop more effective therapeutic interventions by overcoming this resistance problem, we combined the histone deacetylase inhibitor, MPT0E028, with erlotinib in an effort to increase their antitumor effects in erlotinib-resistant lung adenocarcinoma cells. This combined treatment yielded significant growth inhibition, induced the expression of apoptotic proteins (PARP, γH2AX, and caspase-3), increased the levels of acetylated histone H3, and showed synergistic effects in vitro and in vivo. These effects were independent of the mutation status of the genes encoding EGFR or K-Ras. MPT0E028 synergistically blocked key regulators of the EGFR/HER2 signaling pathways, attenuating multiple compensatory pathways (e.g., AKT, extracellular signal-regulated kinase, and c-MET). Our results indicate that this combination therapy might be a promising strategy for facilitating the effects of erlotinib monotherapy by activating various networks. Taken together, our data provide compelling evidence that MPT0E028 has the potential to improve the treatment of heterogeneous and drug-resistant tumors that cannot be controlled with single-target agents." @default.
• W2045477218 created "2016-06-24" @default.
• W2045477218 creator A5016825023 @default.
• W2045477218 creator A5024894709 @default.
• W2045477218 creator A5034187837 @default.
• W2045477218 creator A5040094053 @default.
• W2045477218 creator A5053529693 @default.
• W2045477218 creator A5057587453 @default.
• W2045477218 creator A5075967549 @default.
• W2045477218 date "2013-09-19" @default.
• W2045477218 modified "2023-10-17" @default.
• W2045477218 title "The HDAC inhibitor, MPT0E028, enhances erlotinib-induced cell death in EGFR-TKI-resistant NSCLC cells" @default.
• W2045477218 cites W1931438814 @default.
• W2045477218 cites W1967018540 @default.
• W2045477218 cites W1967394241 @default.
• W2045477218 cites W1970476748 @default.
• W2045477218 cites W1974024530 @default.
• W2045477218 cites W1977332018 @default.
• W2045477218 cites W1986047321 @default.
• W2045477218 cites W1997495854 @default.
• W2045477218 cites W1998971866 @default.
• W2045477218 cites W2001362643 @default.
• W2045477218 cites W2002937040 @default.
• W2045477218 cites W2003984225 @default.
• W2045477218 cites W2014238399 @default.
• W2045477218 cites W2019084941 @default.
• W2045477218 cites W2039633811 @default.
• W2045477218 cites W2055103019 @default.
• W2045477218 cites W2058131495 @default.
• W2045477218 cites W2063391304 @default.
• W2045477218 cites W2065108275 @default.
• W2045477218 cites W2074350030 @default.
• W2045477218 cites W2090029719 @default.
• W2045477218 cites W2093487709 @default.
• W2045477218 cites W2096439168 @default.
• W2045477218 cites W2099803844 @default.
• W2045477218 cites W2105906697 @default.
• W2045477218 cites W2107277218 @default.
• W2045477218 cites W2110835998 @default.
• W2045477218 cites W2113452945 @default.
• W2045477218 cites W2118661220 @default.
• W2045477218 cites W2121389354 @default.
• W2045477218 cites W2127101185 @default.
• W2045477218 cites W2130027352 @default.
• W2045477218 cites W2130284499 @default.
• W2045477218 cites W2133963438 @default.
• W2045477218 cites W2134964659 @default.
• W2045477218 cites W2135836172 @default.
• W2045477218 cites W2138050607 @default.
• W2045477218 cites W2138309116 @default.
• W2045477218 cites W2138536086 @default.
• W2045477218 cites W2138896702 @default.
• W2045477218 cites W2140062641 @default.
• W2045477218 cites W2143913849 @default.
• W2045477218 cites W2145618171 @default.
• W2045477218 cites W2145953198 @default.
• W2045477218 cites W2146625800 @default.
• W2045477218 cites W2153156618 @default.
• W2045477218 cites W2154042421 @default.
• W2045477218 cites W2162546868 @default.
• W2045477218 cites W2162724777 @default.
• W2045477218 cites W2164569674 @default.
• W2045477218 cites W2165187741 @default.
• W2045477218 cites W2167620731 @default.
• W2045477218 cites W2168258970 @default.
• W2045477218 cites W30401430 @default.
• W2045477218 doi "https://doi.org/10.1038/cddis.2013.330" @default.
• W2045477218 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3789188" @default.
• W2045477218 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24052078" @default.
• W2045477218 hasPublicationYear "2013" @default.
• W2045477218 type Work @default.
• W2045477218 sameAs 2045477218 @default.
• W2045477218 citedByCount "66" @default.
• W2045477218 countsByYear W20454772182014 @default.
• W2045477218 countsByYear W20454772182015 @default.
• W2045477218 countsByYear W20454772182016 @default.
• W2045477218 countsByYear W20454772182017 @default.
• W2045477218 countsByYear W20454772182018 @default.
• W2045477218 countsByYear W20454772182019 @default.
• W2045477218 countsByYear W20454772182020 @default.
• W2045477218 countsByYear W20454772182021 @default.
• W2045477218 countsByYear W20454772182022 @default.
• W2045477218 countsByYear W20454772182023 @default.
• W2045477218 crossrefType "journal-article" @default.
• W2045477218 hasAuthorship W2045477218A5016825023 @default.
• W2045477218 hasAuthorship W2045477218A5024894709 @default.
• W2045477218 hasAuthorship W2045477218A5034187837 @default.
• W2045477218 hasAuthorship W2045477218A5040094053 @default.
• W2045477218 hasAuthorship W2045477218A5053529693 @default.
• W2045477218 hasAuthorship W2045477218A5057587453 @default.
• W2045477218 hasAuthorship W2045477218A5075967549 @default.
• W2045477218 hasBestOaLocation W20454772181 @default.
• W2045477218 hasConcept C121608353 @default.
• W2045477218 hasConcept C126322002 @default.
• W2045477218 hasConcept C185592680 @default.
• W2045477218 hasConcept C2776256026 @default.
• W2045477218 hasConcept C2777506169 @default.
• W2045477218 hasConcept C2778087573 @default.

• next